Winst gevend schreef op 19 maart 2024 11:12:
PHARM | Pharming Group : Upgrade.
Mar 18, 2024
Price target increased by 11% to €2.00Up from €1.80, the current price target is an average from 3 analysts.
New target price is 90% above last closing price of €1.05.
Stock is up 9.2% over the past year.
The company is forecast to post a net loss per share of US$0.0033 next year
compared to a net loss per share of US$0.015 last year.